3a53d7cf_Guidance_by_month___NICE_uidance_by_month___August_2015_Topic
[Reference] STA [Guidance] In development Crohn's disease (moderate to severe) - vedolizumab [ID690] [Programme] Technology appraisal guidance [Topic] 
Inflammatory bowel disease
Guidance by month | NICE
Topic